At the 2013 International Pharmaceutical Federation (FIP) World Congress hosted in Dublin, Ireland, NABP presented information on online pharmacy safety and rogue online drug sellers to delegates at a session dedicated to online health. NABP shared its finding with delegates that almost 97% of more than 10,000 Internet Web sites selling drug products and reviewed […]

Read More ›

The risks of ordering medications online and of receiving dangerous counterfeit products are highlighted in a recent NBC Connecticut report. In the segment, NBC Connecticut’s investigative troubleshooting team, along with global pharmaceutical security experts from Pfizer explain that many counterfeit drugs contain dangerous ingredients, are created in unsanitary environments, and may not even contain the […]

Read More ›

The National Association of Boards of Pharmacy® (NABP®) today issued a report emphasizing the deceptive practices that illegal online drug sellers use to make consumers believe that they are legitimate, safe, and trustworthy. As detailed in the Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: July 2013 (PDF), NABP discovered numerous […]

Read More ›

A United States House of Representatives subcommittee held a hearing (PDF) July 16, 2013, to examine various bills aimed to implement new frameworks for the regulation of compounding. The Committee on Energy and Commerce, Subcommittee on Health, convened to hear expert testimony from US Food and Drug Administration (FDA) and other experts in health care […]

Read More ›

NABP expressed its support for federal legislation that would distinguish between compounding and manufacturing, in testimony (PDF) presented at a United States House subcommittee hearing on May 23, 2013. The hearing, “Examining Drug Compounding” was held to provide US Committee on Energy and Commerce Health Subcommittee members an opportunity to hear testimony from Food and […]

Read More ›

Under a contract with the New Jersey Division of Consumer Affairs (Division) and the state’s Attorney General Jeffrey S. Chiesa, NABP will assist the Division with inspections of New Jersey pharmacies engaged in the practice of compounding. The planned pharmacy surveys will expand the Division’s already robust inspections of compounding pharmacies. As noted in a […]

Read More ›

The National Association of Boards of Pharmacy® (NABP®) today issued a report emphasizing that the global distribution of counterfeit and substandard medications, fueled by illegal online sellers, demands an international response. As detailed in the Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: April 2013, NABP has partnered with regulatory authorities, […]

Read More ›

The National Association of Boards of Pharmacy® (NABP®) today issued a report outlining how continued collaboration among global stakeholders is vital to eliminating the public health threats posed by rogue Internet drug outlets. The Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: January 2013, details the Association’s five-year progress in providing […]

Read More ›

The National Association of Boards of Pharmacy® (NABP®) today issued a report about the importance of collaboration among members of the international pharmacy community to protect patients worldwide from dangers posed by illegal online drug sellers. As described in the Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: October 2012, global […]

Read More ›

New United States Pharmacopeial Convention (USP) standards for a universal approach to the format, appearance, content, and instructions for medicines in containers dispensed by pharmacists have been released. “Wide variability in prescription container labels exists today across individual prescriptions, pharmacies, retail chains and states. The USP standards provide specific direction on how to organize labels […]

Read More ›